Skip to content
ppharmaranks
Menu

Best treatments for retinal vein occlusion

5 products may treat retinal vein occlusion, spanning FDA drug classes such as vascular endothelial growth factor inhibitor. The current highest-rated option is lucentis. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 5 drugs we list for retinal vein occlusion, none are yet flagged as generics in our price data, spanning classes such as vascular endothelial growth factor inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for retinal vein occlusion — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Top-rated picks for retinal vein occlusion: 1. Lucentis · 2. Susvimo · 3. Cimerli

Top-rated treatments for retinal vein occlusion, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100View →
270/100View →
368/100View →
4Not yet ratedView →
5Not yet ratedView →

Full ranking · 5 treatments

Frequently asked

What treats retinal vein occlusion?
Our catalog lists 5 products that may treat retinal vein occlusion, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is lucentis.
What is the best-rated treatment for retinal vein occlusion?
By our independent recall-safety rating — not an efficacy measure — lucentis ranks highest among the products we list for retinal vein occlusion. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat retinal vein occlusion?
Treatments for retinal vein occlusion span FDA drug classes including vascular endothelial growth factor inhibitor. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.